Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Invested Capital (2016 - 2025)

Historic Invested Capital for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $5.0 million.

  • Silo Pharma's Invested Capital fell 2614.8% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 2614.8%. This contributed to the annual value of $5.0 million for FY2024, which is 1849.81% down from last year.
  • According to the latest figures from Q3 2025, Silo Pharma's Invested Capital is $5.0 million, which was down 2614.8% from $4.9 million recorded in Q2 2025.
  • Silo Pharma's 5-year Invested Capital high stood at $11.9 million for Q3 2022, and its period low was $3.8 million during Q2 2021.
  • Over the past 5 years, Silo Pharma's median Invested Capital value was $6.8 million (recorded in 2024), while the average stood at $7.2 million.
  • In the last 5 years, Silo Pharma's Invested Capital surged by 171766.93% in 2021 and then crashed by 4762.46% in 2024.
  • Over the past 5 years, Silo Pharma's Invested Capital (Quarter) stood at $9.5 million in 2021, then increased by 12.92% to $10.7 million in 2022, then plummeted by 42.3% to $6.2 million in 2023, then fell by 18.5% to $5.0 million in 2024, then decreased by 0.51% to $5.0 million in 2025.
  • Its Invested Capital was $5.0 million in Q3 2025, compared to $4.9 million in Q2 2025 and $4.0 million in Q1 2025.